1. Cellular Effects of Selected Unsymmetrical Bisacridines on the Multicellular Tumor Spheroids of HCT116 Colon and A549 Lung Cancer Cells in Comparison to Monolayer Cultures
   Jolanta Kulesza et al, 2023, International Journal of Molecular Sciences CrossRef
2. Aptamers in Non-Small Cell Lung Cancer Treatment
   Irena Wieleba et al, 2020, Molecules CrossRef
3. The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies
   Oluwaseun Adebayo Bamodu et al, 2024, Frontiers in Oncology CrossRef
4. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts
   Albin Rudisch et al, 2015, PLOS ONE CrossRef
5. Bufalin Suppresses Colorectal Cancer Cells by the Blockade of Canonical Wnt Signaling Pathway
   Wanmi Sui et al, 2022, 2022 4th International Conference on Intelligent Medicine and Image Processing CrossRef
6. Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum
   Jose Francisco Islas et al, 2022, Cancers CrossRef
7. Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells
   Xiaoyu Yang et al, 2017, Redox Biology CrossRef
8. Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside
   Yiyang Liu et al, 2022, Experimental Hematology & Oncology CrossRef
9. Small Molecule Inhibitor YM155-Mediated Activation of Death Receptor 5 Is Crucial for Chemotherapy-Induced Apoptosis in Pancreatic Carcinoma
   Xiangxuan Zhao et al, 2015, Molecular Cancer Therapeutics CrossRef
10. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway
    JI QIN GAI et al, 2016, International Journal of Oncology CrossRef
11. Clinical Impact of the Epithelial-Mesenchymal Transition in Lung Cancer as a Biomarker Assisting in Therapeutic Decisions
    Julien Ancel et al, 2022, Cells Tissues Organs CrossRef
12. Progress and application of circulating tumor cells in non-small cell lung cancer
    Huizhu Qian et al, 2021, Molecular Therapy - Oncolytics CrossRef
13. Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
    Qingxin Fan et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
14. Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy
    Galatea Kallergi et al, 2022, Cancers CrossRef
15. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells
    Xue Liu et al, 2019, Journal of Cellular Physiology CrossRef
16. Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients
    Evangelia Pantazaka et al, 2021, Cancers CrossRef
17. The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
    Alexandra Kölbl et al, 2016, International Journal of Molecular Sciences CrossRef
18. Combination treatment of gemcitabine and sorafenib exerts a synergistic inhibitory effect on non‑small cell lung cancer in�vitro and in�vivo via the epithelial‑to‑mesenchymal transition process
    Shanshan Jiang et al, 2020, Oncology Letters CrossRef